Recent Trends in Clot Retrieval Devices: A Review

Area of Science:

• Neurology
• Biomedical Engineering
• Interventional Radiology

Background:

• Stroke is a leading global cause of death, with limited efficacy of current treatments like intravenous thrombolysis.
• Existing therapies for acute ischemic stroke, including intravenous (IV) and intra-arterial (IA) thrombolysis, have not significantly reduced mortality rates.
• The need for improved recanalization strategies led to the development of endovascular clot retrieval devices.

Purpose of the Study:

• To provide an in-depth review of various endovascular clot retrieval devices.
• To discuss the recent FDA clearance of these devices as first-line treatment for acute ischemic stroke.
• To compare the efficacy of clot retrieval devices with the current gold standard treatment.

Main Methods:

• Review of existing literature and clinical data on endovascular clot retrieval devices.
• Analysis of the evolution and design of mechanical thrombectomy devices.
• Comparison of outcomes between clot retrieval devices and intravenous rt-PA therapy.

Main Results:

• Initial endovascular devices showed promise but required significant improvements.
• Recent advancements have led to FDA approval of several clot retrieval devices as first-line therapy.
• These devices enable mechanical recanalization of occluded arteries in stroke patients.

Conclusions:

• Endovascular clot retrieval devices represent a significant advancement in acute ischemic stroke treatment.
• The new FDA clearance positions these devices as a crucial component of stroke management, alongside IV rt-PA.
• Continued innovation in device design is essential for further improving patient outcomes in stroke care.